Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenoma. - Test2 - elhamkhani - TriplyDB

Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenoma.

Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenoma.

http://www.wikidata.org/entity/Q35783253

about

Assessment of age-related changes in heritability and IGF-1 gene effect on circulating IGF-1 levels.Specific metabolic biomarkers as risk and prognostic factors in colorectal cancer.Identification of the IGF1/PI3K/NF κB/ERK gene signalling networks associated with chemotherapy resistance and treatment response in high-grade serous epithelial ovarian cancer Higher IGFBP-1 to IGF-1 serum ratio predicts unfavourable survival in patients with nasopharyngeal carcinoma.Celecoxib inhibits insulin-like growth factor 1 induced growth and invasion in non-small cell lung cancer The therapeutic potential of IGF-I in skeletal muscle repair.Impact of targeting insulin-like growth factor signaling in head and neck cancers.Plasma insulin, glucose, IGF-I, IGF-II, and IGFBP-3 and risk of recurrent colorectal adenomas Possible roles of insulin, IGF-1 and IGFBPs in initiation and progression of colorectal cancer.Type I insulin-like growth factor receptor signaling in hematological malignancies.Hyperinsulinemia, insulin resistance, vitamin D, and colorectal cancer among whites and African Americans.Insulin-like growth factor I and risk of incident cancer in elderly men - results from MrOS (Osteoporotic Fractures in Men) in Sweden.Potential biomarkers for paclitaxel sensitivity in hypopharynx cancer cell Adiponectin, Leptin, IGF-1, and Tumor Necrosis Factor Alpha As Potential Serum Biomarkers for Non-Invasive Diagnosis of Colorectal Adenoma in African Americans.Treatment with Growth Hormone for Adults with Growth Hormone Deficiency Syndrome: Benefits and Risks.

P2860

Q33848720-EB04663A-4D46-4E9B-A161-729D93193B9F Q34008787-42EE8EC4-63EE-44E1-8A35-6122B9FA6E71 Q35044404-FAFFA9E4-8C99-4541-9BA8-FE943D892858 Q36265430-4B608923-692A-4F7C-8F90-546A4854F77A Q36981423-AE5B6161-16B8-433B-AB23-88258FE2F915 Q37068201-04614BCE-8B9E-4ADF-BBAA-624FC7333CAA Q37126107-09911980-B2C6-4303-A958-64A47333AECD Q37579744-1DBBC11E-8F6E-4834-B8FB-BA13673C9329 Q37587287-F00CE64B-4B37-4A95-B0CE-5F47498BFB55 Q37702186-6707445D-A9F7-4EF9-BB44-7DB7EBCEF38C Q38007887-945DED21-72D7-48D2-ABE3-A985D88065DC Q38956253-4EDBA7FE-DEF2-4FD4-A94E-6C6789236749 Q39051376-07976994-4351-41A1-92F2-0DBDA6D5FB9D Q53697698-4ECF3AEF-E474-4AE1-AC67-E4E38AEC1656 Q55349083-B7BE8441-FB4A-4DB3-923F-5115C06468B0

P2860

Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenoma.

http://www.wikidata.org/entity/Q35783253

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenoma.

@ast

Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenoma.

@en

type

label

Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenoma.

@ast

Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenoma.

@en

prefLabel

Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenoma.

@ast

Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenoma.

@en

P1433

Q35783253-128E4163-F0DF-4832-BC37-B74831496707

P1476

Q35783253-0631E62F-930B-4C2D-B637-BBDA767AA29E

P2093

Q35783253-3BE9AF9B-E002-49C5-8FF4-55A0991FAE2D

Q35783253-5E73DA41-ED29-46AD-AF80-3931010587F6

Q35783253-A0C3B745-CE0E-4B16-8582-67A3904D70A6

Q35783253-A820F752-6161-439C-A2DA-26532944357B

Q35783253-B59337FC-AC44-4519-AB7D-E4B7FC058261

Q35783253-D2F73AE9-9827-4E03-AD55-7B006DF686B6

Q35783253-DF25B9AB-E4CC-457F-B011-B3BDB2CA9ED3

Q35783253-E1CAE31A-2951-4574-ADBE-1E5DF6BED6CD

Q35783253-E8C8CB2B-28EB-4AE0-B6D6-613FB088C41C

Q35783253-F557B303-5D62-4C57-9DD6-3F710C530F89

P2860

Q35783253-0B83E5BD-43D0-4B49-BDAA-E9CB285852E2

Q35783253-10872310-DC1F-4F93-AD0D-B93E7405F7BC

Q35783253-1601EFFD-D9FA-400C-AE67-8D87CCA56482

Q35783253-17BBFD7E-3097-4714-A2A5-A1162C0FB0CB

Q35783253-18F663D2-C3ED-4095-BEFA-CD62859A892C

Q35783253-1DDAEEC1-9A9E-4ED7-9130-3935CCF8860B

Q35783253-1E8E4955-93BB-4A66-8549-EDB3C9082425

Q35783253-1FB5031A-379F-4CCA-9CB3-42A93063BCAD

Q35783253-26D07964-5E58-406C-AC6C-8825AA377357

Q35783253-2BB067FA-D5CD-49D3-AF9C-DB4A7ED4FD99

P304

Q35783253-DF5036F8-F6A5-4F4B-898A-45CE7CB77A83

P31

Q35783253-9EE5A790-E9A8-4DED-A32B-300C049AD02E

P356

Q35783253-C45BED3B-F3A8-4E7A-901E-C13DA882D7A8

P433

Q35783253-03A842A4-BB10-4433-9AEA-71E0713CDE84

P478

Q35783253-7084DB58-2B41-4149-8D8C-622A9A630CF8

P50

Q35783253-49771950-6131-4F5B-A4C9-2560A49FB71B

P577

Q35783253-17CDCFF0-CD05-4073-B2C3-4DF04D979BE7

P5875

Q35783253-B22B8287-E1F9-4CA2-96FB-DF40E84924E2

P698

Q35783253-52AC7A9D-8888-49A6-A29B-1AA1F5DB8301

P932

Q35783253-E34B0E2C-5D44-49EE-A685-023933448753

P356

P1433

International Journal of Cancer

P1476

Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenoma

@en

P2093

Barry Graubard

http://www.w3.org/2001/XMLSchema#string

Hormuzd Katki

http://www.w3.org/2001/XMLSchema#string

Mark H Greene

http://www.w3.org/2001/XMLSchema#string

Michael Martin

http://www.w3.org/2001/XMLSchema#string

Michael Pollak

http://www.w3.org/2001/XMLSchema#string

Richard B Hayes

http://www.w3.org/2001/XMLSchema#string

Robert E Schoen

http://www.w3.org/2001/XMLSchema#string

Sonja I Berndt

http://www.w3.org/2001/XMLSchema#string

Ying Gao

http://www.w3.org/2001/XMLSchema#string

Yuzhen Tao

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2010

A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women

Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions

Insulin-like growth factors and their binding proteins: biological actions

Nocturnin suppresses igf1 expression in bone by targeting the 3' untranslated region of igf1 mRNA

Insulin and insulin-like growth factor signalling in neoplasia

Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies.

Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies

Associations of plasma C-peptide and IGFBP-1 levels with risk of colorectal adenoma in a multiethnic population.

Control of growth by the somatropic axis: growth hormone and the insulin-like growth factors have related and independent roles.

P304

E105-13

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.26438

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

131

http://www.w3.org/2001/XMLSchema#string

P50

Timothy R. Church

P577

2011-11-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51656431

http://www.w3.org/2001/XMLSchema#string

P698

21932422

http://www.w3.org/2001/XMLSchema#string

P932

3288254

http://www.w3.org/2001/XMLSchema#string